NCT00087425 2015-04-30
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
9 trialsNCT00006389 2014-10-01
Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006942 2013-08-26
Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005965 2013-07-10
Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix
National Cancer Institute (NCI)
Phase 2 Completed
NCT00004008 2013-06-26
Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005056 2013-06-26
Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003968 2013-02-08
Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00002725 2013-02-05
Bryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00058305 2013-01-10
Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation
National Cancer Institute (NCI)
Phase 2 Completed